Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 8, 2023 (09:27)

Sector: Healthcare

The share price of Dicerna Pharmaceuticals, Inc. (DRNA) now

What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Dicerna Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Dicerna Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Dicerna Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Dicerna Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Dicerna Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Dicerna Pharmaceuticals stock? When should I record a loss on Dicerna Pharmaceuticals stock? What are analysts' forecasts for Dicerna Pharmaceuticals stock? What is the future of Dicerna Pharmaceuticals stock? We forecast Dicerna Pharmaceuticals stock performance using neural networks based on historical data on Dicerna Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Dicerna Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Dicerna Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Dicerna Pharmaceuticals stock

The chart below shows the historical price of Dicerna Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Dicerna Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Dicerna Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 10 39.22 38.76 39.70 2.43
Jun 11 39.61 39.28 40.52 3.16
Jun 12 39.86 39.28 40.36 2.76
Jun 13 39.01 38.76 39.48 1.87
Jun 14 39.34 39.02 39.91 2.29
Jun 15 39.02 38.46 40.00 4.03
Jun 16 38.56 37.96 39.26 3.41
Jun 17 38.15 37.66 38.64 2.59
Jun 18 38.99 38.64 39.45 2.10
Jun 19 37.89 37.61 38.75 3.03
Jun 20 37.92 36.99 38.68 4.56
Jun 21 39.07 38.27 39.92 4.31
Jun 22 38.76 38.46 39.33 2.26
Jun 23 39.09 38.55 39.58 2.66
Jun 24 39.79 39.50 40.53 2.61
Jun 25 39.64 38.84 40.51 4.31
Jun 26 40.22 39.64 40.70 2.66
Jun 27 40.26 39.95 40.76 2.03
Jun 28 39.33 38.38 39.84 3.80
Jun 29 38.26 37.82 39.22 3.69
Jun 30 37.86 37.00 38.33 3.60
Jul 01 37.27 36.43 37.85 3.90
Jul 02 37.06 36.38 37.30 2.54
Jul 03 36.74 36.27 36.98 1.94
Jul 04 37.12 36.82 37.78 2.61
Jul 05 37.67 37.16 38.28 3.02
Jul 06 37.23 36.37 38.10 4.75
Jul 07 37.72 36.76 38.60 5.02
Jul 08 38.00 37.74 38.45 1.87
Jul 09 37.78 37.50 38.30 2.13

Dicerna Pharmaceuticals Daily Price Targets


Dicerna Pharmaceuticals Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $39.22.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.371%.
Pessimistic target level: 38.76
Optimistic target level: 39.70

Dicerna Pharmaceuticals Stock Forecast 06-11-2023.

Forecast target price for 06-11-2023: $39.61.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.065%.
Pessimistic target level: 39.28
Optimistic target level: 40.52

Dicerna Pharmaceuticals Stock Forecast 06-12-2023.

Forecast target price for 06-12-2023: $39.86.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.686%.
Pessimistic target level: 39.28
Optimistic target level: 40.36

Dicerna Pharmaceuticals Stock Forecast 06-13-2023.

Forecast target price for 06-13-2023: $39.01.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 1.834%.
Pessimistic target level: 38.76
Optimistic target level: 39.48

Dicerna Pharmaceuticals Stock Forecast 06-14-2023.

Forecast target price for 06-14-2023: $39.34.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.240%.
Pessimistic target level: 39.02
Optimistic target level: 39.91

Dicerna Pharmaceuticals Stock Forecast 06-15-2023.

Forecast target price for 06-15-2023: $39.02.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.870%.
Pessimistic target level: 38.46
Optimistic target level: 40.00

DRNA (DRNA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jul. 35.96 32.68 39.81 17.92
Aug. 36.88 34.28 38.53 11.03
Sep. 34.22 31.43 38.33 18.00
Oct. 35.76 31.29 37.59 16.74
Nov. 36.73 34.55 41.25 16.24
Dec. 34.50 31.18 37.53 16.91

Dicerna Pharmaceuticals forecast for this year


Dicerna Pharmaceuticals Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $35.9574. Pessimistic: $32.68. Optimistic: $39.81


Dicerna Pharmaceuticals Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $36.8779. Pessimistic: $34.28. Optimistic: $38.53


Dicerna Pharmaceuticals Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $34.2227. Pessimistic: $31.43. Optimistic: $38.33


Dicerna Pharmaceuticals Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $35.7559. Pessimistic: $31.29. Optimistic: $37.59


Dicerna Pharmaceuticals Stock Prediction for Nov 2023

An uptrend is forecast for this month with an optimal target price of $36.7284. Pessimistic: $34.55. Optimistic: $41.25


Dicerna Pharmaceuticals Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $34.4953. Pessimistic: $31.18. Optimistic: $37.53



Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 34.83 30.54 38.89 21.49
Feb 32.88 29.30 34.93 16.11
Mar 31.88 28.71 35.60 19.34
Apr 32.74 31.43 36.73 14.41
May 29.50 28.08 32.52 13.64
Jun 27.61 25.13 28.80 12.73
Jul 28.98 25.69 30.00 14.37
Aug 27.96 26.62 29.43 9.57
Sep 26.39 24.03 28.67 16.20
Oct 25.12 22.11 26.41 16.29
Nov 25.49 24.06 27.48 12.46
Dec 26.42 25.58 29.60 13.57

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 29.76 27.62 33.38 17.26
Feb 25.38 24.00 26.72 10.18
Mar 26.07 22.99 27.95 17.76
Apr 27.37 24.35 28.99 16.01
May 29.21 26.82 31.36 14.46
Jun 30.42 28.81 33.44 13.83
Jul 34.17 31.33 37.39 16.23
Aug 33.18 29.42 34.83 15.55
Sep 34.30 31.50 36.11 12.77
Oct 36.00 34.10 40.15 15.06
Nov 36.98 35.44 39.88 11.13
Dec 34.02 30.97 37.61 17.66

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 29.88 26.78 32.80 18.37
Feb 33.28 30.35 37.54 19.15
Mar 33.71 32.14 35.27 8.87
Apr 33.44 30.81 34.72 11.25
May 31.35 28.89 32.45 10.97
Jun 30.70 27.26 33.64 18.98
Jul 33.30 29.14 34.90 16.49
Aug 32.61 29.32 33.91 13.54
Sep 34.96 32.38 37.03 12.54
Oct 36.02 32.62 40.17 18.79
Nov 34.58 30.48 38.45 20.72
Dec 32.03 29.21 35.11 16.79

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 31.06 28.62 33.49 14.54
Feb 29.67 28.48 30.85 7.69
Mar 33.23 29.35 35.14 16.49
Apr 35.09 32.17 38.40 16.23
May 38.12 34.22 42.69 19.86
Jun 36.35 34.90 39.26 11.11
Jul 41.99 37.09 43.74 15.21
Aug 41.99 38.23 43.74 12.60
Sep 47.70 45.03 53.66 16.07
Oct 49.31 46.70 52.54 11.11
Nov 53.17 47.98 57.26 16.20
Dec 52.75 48.87 56.12 12.93

Dicerna Pharmaceuticals information and performance

Biopharmaceutical company Dicerna Pharmaceuticals, Inc. specializes in the discovery and development of pharmaceuticals based on the interference of ribonucleic acid (RNAi). The company develops pharmaceuticals using its GalXC RNAi platform to treat liver diseases, including rare diseases, viral infections, chronic liver diseases, and cardiometabolic diseases.

Dicerna Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.